Clinical Trial Detail

NCT ID NCT04465643
Title Neoadjuvant Nivolumab Plus Ipilimumab for Newly Diagnosed Malignant Peripheral Nerve Sheath Tumor
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications

malignant peripheral nerve sheath tumor

atypical neurofibroma

optic nerve glioma

plexiform neurofibroma

malignant glioma

Therapies

Ipilimumab + Nivolumab

Age Groups: adult child senior

No variant requirements are available.